Given the high predominance of bone metastasis in CRPC patients and their possible exclusive presence [17], with the current study we wanted to retrospectively analyze the incidence of bone-only PSMA uptake in a population of consecutive CRPC patients who underwent PSMA PET/CT for restaging. The gene discussed is FOLH1; the disease is bone metastasis.